INTRODUCTION
Diarrhea is a common symptom in hospitalized patients; however, the majority of patients have a non-infectious etiology [1] . In the developed world, Clostridium difficile infection (CDI) is the most important cause of nosocomial infectious diarrhea [2] . In addition to providing epidemiological data and helping to indicate that a local outbreak may be occurring, Other studies have found that as much as 40-62% of empirical therapy for C. difficile is inappropriate [3, 6] . Thus, there is a clinical need for a rapid diagnostic test that can help clinicians make informed decisions quicker, minimizing waste and potentially improving clinical outcomes.
The majority of microbiology tests are performed in centralized laboratories;
however, delays are encountered due to two main bottlenecks: transportation to the laboratory and batching of specimens to be tested. There has been a recent trend towards centralization and consolidation of pathology services, which can adversely affect turnaround times [7, 8] . These problems may be partially resolved by the use of point-ofcare tests (POCT), which have been introduced for a number of infectious diseases [7] [8] [9] [10] [11] [12] [13] [14] . The rapid turnaround times of POCTs are potentially beneficial for making decisions in a variety of situations: isolation of infectious patients (and de-isolation of non-infectious ones); avoidance of unnecessary hospitalization; avoidance of unnecessary treatment (including reduced length of therapy); and improved selection of antimicrobial therapy (e.g., using a more appropriate, narrower spectrum agent) [7] .
There are few reports in the literature of efforts to reduce laboratory turnaround times for C. difficile testing. Verdoorn and colleagues assessed the effect of telephoning out positive C. difficile results on the time to ordering antimicrobial therapy, which was reduced from a mean of 11.9-3.6 h [15] . Barbut and colleagues noted that changing their laboratory testing from a cytotoxicity assay to either PCR alone or in combination with glutamate dehydrogenase (GDH) led to a significant reduction in turnaround time from a mean of 3.5-0.55 days. This was associated with a reduction in unnecessary empirical therapy, length of stay and a non-significant reduction in mortality [16] .
The present literature on real-world assessment of POCT for infectious diseases is limited [9] and no studies have evaluated C.
difficile testing in a near-patient environment. This is mostly due to the lack of commercially available assays that can be used for this purpose. However, several manufacturers are developing highly sensitive molecular-based tests that could be implemented at POCT.
These tests have been proposed or evaluated in a number of infectious diseases e.g., MRSA [10] , influenza [17] , sexually transmitted infections [11] , group B Streptococcus [12] , tuberculosis [13] and HIV [14] .
The authors performed a feasibility study to evaluate acceptability, ease of use, change in 
METHODS

Setting
The study was conducted in a central London academic hospital, with 1,100 beds, including 180 individual isolation rooms. Patients admitted with or who develop diarrhea and/or vomiting are placed in these rooms (with private bathroom), and kept there until at least 48 h following return to normal bowel habit. If this is not possible, the patient is placed in a cohorted, or an otherwise unoccupied, bay.
Clinicians are advised to investigate all cases of diarrhea (two or more liquid stools in 24 h). The rate of CDI in our institution between April 2011 and March 2012 was 32.2 cases per 100,000 occupied bed days (OBD). This compares to a national rate of 61.9 cases per 100,000 OBD for the same period.
The UK does not define technical criteria for assessing the suitability of POCT; however, there are local guidelines which are overseen by a Point of Care Committee in our hospital [18] .
The study was conducted between March 2011 and January 2013 (22 months) in two settings; three adjacent older persons' wards comprising a total of 85 beds, and two adjacent ICUs comprising a total of 30 beds. Comparator wards, consisting of one older persons' ward and one ICU, had access only to laboratorybased testing and were used to compare study wards to investigate potential clinical utility.
Members of staff were asked to test any patient with clinically significant diarrhea for CDI using the POCT (GeneXpert Ò ); the residual sample was then tested in the centralized laboratory. The 
Compliance with Ethics Guidelines
All procedures followed were in accordance with the ethical standards of the responsible 
Staff Training
Nurses, healthcare assistants (older persons' wards) and laboratory technicians (ICUs) were trained to use the POCT system by a research nurse. This generally took around 1 h and was done in small groups. Training consisted of a demonstration followed by direct observation of each staff member to ensure competence. Competent staff members were provided with a password to operate the GeneXpert Ò system. Additional training was provided to those requiring it. The research nurse was available between the hours of 9 am and 5 pm, Monday to Friday, to assist with any problems and train new staff members.
Connectivity and Results
The GeneXpert Ò systems were networked using 
Acceptability and Ease of Use
Agreement with Laboratory Testing
Of the 335 samples that were tested using the POCT, 20 (6%) were either not received by the laboratory or there was insufficient material to perform further testing. Of the remaining 315 samples, 274 (87%) were negative by both POCT and laboratory-based GDH, and 15 (4.8%) were negative by POCT, positive by laboratory-based GDH but negative by laboratory-based PCR; these samples were considered to be non-discrepant. The remaining 26 (8.2%) samples were positive by POCT; of these 20 were also laboratory-based GDH and PCR positive (considered nondiscrepant) and 6 were laboratory-based GDH negative (considered discrepant). Overall agreement was 98.1%. In total, there were 6 (1.9%) discrepant samples with a mean cycle threshold (Ct) value of 32.9. The maximum valid Ct for the toxin B target is 37. Discrepant samples were more likely to occur on elderly wards (n = 3, 3.9% of those tested) than ICU (n = 3, 1.3% of those tested), although this was not significant.
Processing Errors
Overall 20/335 (6%) processing errors were encountered where a result was not obtained.
These resulted from a variety of user and platform errors and were greatest in the first few months of the study (ten (20.4%) errors in 49 tests performed in quarter one compared with two (3.3%) errors in 61 tests performed in quarter five). During the second half of the study, an updated GeneXpert Ò cartridge was introduced by the manufacturer, which had pre-filled reagents; this further simplified assay setup and reduced hands on time, although this did not have any effect on the number of processing errors. Overall, significantly more processing errors occurred on the older persons' wards 13/102 (12.7%) than on ICU 7/271 (2.6%) p =\0.001.
Clinical Utility
The mean age of all patients tested with the POCT was 66 years; with a lower mean age in the ICU patients (59 years) compared with older persons' patients (85 years).
A greater proportion of patients tested positive in the older persons' wards (14.4% and 17.4% of those tested by the POCT and the laboratory-based test, respectively) compared with ICU patients (6.9% and 6.6% of those tested by the POCT and the laboratory-based test, respectively).
Overall, most patients were tested well into their hospital admission (mean of 16 days following admission). This corresponds with a high proportion of patients being classified as having hospital-associated diarrhea (onset of symptoms on day 3 or more following admission). However, of the older persons' patients, significantly more had hospital onset diarrhea in those tested with the laboratorybased test only (97% compared with 84% for those were tested with the POCT).
Differences
in patient demographics, ancillary clinical investigations and outcomes between patients tested by POCT and those in comparator wards tested in the laboratory are shown in Table 1 . There were no significant differences in terms of length of stay and allcause mortality rates. Overall 30-day all-cause mortality rate was 5.1 per 1,000 inpatient days (25.3%), which is slightly less than that reported elsewhere [20] . Older persons' patients who had POCT were significantly less likely to have a test requested for bacterial stool culture (3.1% vs. 10.9% p = 0.044). This difference was not observed in the ICU patients. No other differences in ancillary test requesting were observed.
Acceptability and Qualitative Feedback from Operators
A user questionnaire was completed by 85 staff members in two phases (40 in phase one and 45 in phase two, following the introduction of the new GeneXpert Ò cartridges). Staff were permitted to participate in both phases. Sixtysix respondents (78%) were older persons' staff and 19 (22%) were ICU staff. All ICU staff in both rounds agreed that the test was easy to perform, compared with 76% of older persons' staff. The proportion of older persons' staff who agreed with this comment was no different in either phase of the questionnaire. All ICU respondents and 88% of older persons' respondents agreed that POCT results were available faster than laboratory testing. Seventy-six percent of ICU respondents liked being able to perform the test themselves and 94% felt it was an acceptable part of their role. This compares with 86% and 80%, respectively, in older persons' respondents. 95% of ICU respondents and 86% of older persons' respondents thought that the test had helped them to manage beds more effectively (Fig. 2) .
DISCUSSION
Diarrhea and CDI are major infection control challenges for hospitals and clinicians must decide on the most efficient use of scarce resources. Laboratory-based testing for C.
difficile is sometimes slow but POCT could provide a faster result.
The data show that use of this POCT system is feasible in both the older persons' wards and the ICUs studied. However, more problems were encountered in the older persons' wards (more discrepant results and more processing errors).
Although most older persons' staff reported that
the test was easy to perform, this staff group are unfamiliar with carrying out this type of procedure. The ICU technicians were much more familiar with basic laboratory processes and this may account for the lower number of discrepant results and processing errors. The number of errors did not appear to decrease after the introduction of the updated GeneXpert Ò cartridge. [12] .
The turnaround time of the POCT was significantly faster compared with laboratory- Fig. 2 Acceptability and ease of use. A total of 66 older persons' staff and 19 ICU laboratory technicians completed a user questionnaire, asking the level of agreement or disagreement with five statements based on a scale of 1 (completely agree) to 5 (completely disagree). The questions were as follows: (1) the POCT is easy to perform, (2) results from the POCT are available faster than the laboratory-based test, (3) I like being able to perform the POCT myself, (4) performing the POCT is an acceptable part of my role, (5) Sample transportation caused a significant delay in our institution, batching of samples testing in the centralized laboratory also added on additional time, even when samples were tested twice per day. Although the turnaround time was significantly reduced, there were no discernable effects of the POCT on clinical utility other than a reduction in ancillary bacterial culture testing. This is likely to be a minimal cost saving and does not offset the significant costs of running the POCT. The numbers in this study were modest and the study may be insufficiently powered to detect any changes in clinical outcomes between those tested with POCT compared with those tested by laboratory-based testing. Future studies should look at other outcomes such as severity of disease, time to anti-C. difficile therapy (or deescalation of empiric therapy) and use of isolation facilities. It would be prudent to bear in mind, however, that a negative result for C. difficile does not necessarily mean that the patient can be removed from single room isolation, since the symptoms could be due to another infectious cause such as norovirus.
Ideally the patient would be tested for a range of infectious agents to be confident that they do not pose a risk of cross transmission before deisolating [1] .
UK and European guidance recommends testing for CDI using a two-step algorithm with either GDH or a molecular test as a first stage and confirming any positives with a toxin enzyme immunoassays (EIA) [21, 22] . This study was conceived and carried out before this guidance was published and there is still debate about the clinical interpretation of PCR positive tests in diarrheal patients [23] .
Given the current testing guidelines endorsed by Public Health, England and European Society of Clinical Microbiology and Infectious Diseases (ESCMID), perhaps there could be additional value of this assay in screening newly admitted patients for colonization.
Asymptomatic carriage is widespread amongst hospital inpatients [24] and potential transmission from this group has already been demonstrated [25] . Peri-rectal swabs could provide a more convenient and acceptable sample type for screening patients [26] . The practice of screening for carriage is not widely practiced, however, modeling has shown that this approach may be cost effective [27] .
Financial costs were not evaluated in this study. However, when deciding to implement a POCT, it is important to consider the often hidden costs of support from a local accredited laboratory, and costs of training and maintenance; these should be measured in any future evaluation.
CONCLUSION
This study demonstrates that POCT using the GeneXpert Ò system is feasible and acceptable to nursing staff and technicians working within the two extremes of these hospital-based settings. The assay has already been used in a variety of settings including in resource poor countries [28, 29] . These types of tests are becoming increasingly more common and it is important that they are assessed in the environment for which they are intended with high-quality clinical utility studies, which also evaluate cost effectiveness. 
